JPRN-UMIN000047518招募中未知
Comparison of efficacy and safety of insulin glargine U-100/lixisenatide and insulin degludec/liraglutide in type 2 diabetes patients - Comparison of efficacy and safety of insulin glargine U-100/lixisenatide and insulin degludec/liraglutide in type 2 diabetes patients
Minami Osaka Hospital0 个研究点目标入组 36 人开始时间: 2022年6月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with gastrointestinal disorders such as gastroparesis and inflammatory bowel disease Patients with a history of pancreatitis The following patients or conditions that may cause hypoglycemia Gastrointestinal disorders such as diarrhea and vomiting Pituitary insufficiency or adrenal insufficiency Malnutrition, starvation, irregular dietary intake, lack of dietary intake or weakness Intense muscle exercise Excessive alcohol intake Patients with severe renal dysfunction (eGFR <30 mL/min/1.73 m2) or end-stage renal disease Patients with severe liver dysfunction (high AST or ALT of 100 U/L or more) Patients who have been treated with Insulin glargine U-100/lixisenatide or Insulin degludec/liraglutide in the past Pregnant or potentially pregnant women and lactating patients Other patients judged by the investigator to be inappropriate as subjects
研究者
相似试验
已完成
不适用
Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 Units/mL and insulin glulisine (Basal plus therapy).diabetesJPRN-UMIN000030648Minami Osaka hospital20
招募中
不适用
Efficacy and safety of once daily insulin glargine therapy for people with type 2 diabetes inadequately controlled with DPP4 inhibitor and several OADsType 2 DiabetesJPRN-UMIN000007375Tokyo Medical University100
招募中
不适用
Study of the efficacy and safety of insulin degludec who treating with basal insulin glargine or insulin detemir in type 1 diabetes with the Basal-Bolus TherapyType 1 diabetesJPRN-UMIN000012358Toho University School of Medicine, Division of diabetes, metabolism and endocrinology20
招募中
不适用
Study of the efficacy and safety of insulin degludec who treating with basal insulin glargine or insulin detemir in type 2 diabetes with the Basal-Bolus TherapyJPRN-UMIN000015792Toho University School of Medicine, Division of diabetes, metabolism and endocrinology40
尚未招募
不适用
A clinical trial to study the effect of insulin glargine injection given earlier during diabetic ketoacidosis (DKA) along with regular treatment as compared to regular treatment alone in children with Type-1 DiabetesCTRI/2022/11/047612Aster Intramural funding